Gynecologic Oncology Group 215-854-0770 is a clinical research site located in Philadelphia, Pennsylvania, United States.
Crixeo Health Trust Score: 66/100 (FAIR). This profile has not yet been claimed by the site owner.
Gynecologic Oncology Group 215-854-0770 has participated in 4 clinical trials.
Therapeutic areas: Cervical Intraepithelial Neoplasia, Uterine Neoplasms, Genital Neoplasms, Female.
Sponsors: Eli Lilly and Company.
Trust Score: 66/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Gynecologic Oncology Group 215-854-0770 has a Crixeo Trust Score of 66/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Gynecologic Oncology Group 215-854-0770 has 4 clinical trials on record. Their work covers Cervical Intraepithelial Neoplasia, Uterine Neoplasms, Genital Neoplasms, Female.
Gynecologic Oncology Group 215-854-0770 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.